Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mary V Relling

Showing results (71-80 of 295) with videos related to

Pageof 30
Sort By:
Cancer|March 6, 2008
Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapseNobuko Hijiya, Clinton F Stewart, Yinmei Zhou, et al.
Cancer Research|May 19, 2007
Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamicsChristine Hartford, Erick Vasquez, Matthias Schwab, et al.
Pharmacogenetics and Genomics|April 9, 2014
Host thiopurine methyltransferase status affects mercaptopurine antileukemic effectiveness in a murine modelLaura B Ramsey, Laura J Janke, Mathew J Edick, et al.
Blood|January 26, 2011
Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemiaNidal Boulos, Heather L Mulder, Christopher R Calabrese, et al.
Pediatric Blood & Cancer|December 6, 2021
Dasatinib does not exacerbate dexamethasone-induced osteonecrosis in murine models of acute lymphoblastic leukemia therapyEmily R Finch, Laura J Janke, Lie Li, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemiaJohn Carl Panetta, Yuri Yanishevski, Ching-Hon Pui, et al.
Pediatric Blood & Cancer|June 14, 2021
Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical modelsLaura J Janke, Jieun Kim, Monique A Payton, et al.
Blood|December 11, 2008
Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemiaDeborah French, Wenjian Yang, Cheng Cheng, et al.
Pediatric Blood & Cancer|December 31, 2016
Osteonecrosis is unrelated to hip anatomy in children with acute lymphoblastic leukemiaMary V Portera, Seth E Karol, Colton Smith, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2024
Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research HospitalAlyssa Gaietto, John C Panetta, Jennifer L Pauley, et al.
Pageof 30

Showing results (71-80 of 295) with videos related to

Sort By:
Pageof 30
Cancer|March 6, 2008
Phase II study of topotecan in combination with dexamethasone, asparaginase, and vincristine in pediatric patients with acute lymphoblastic leukemia in first relapseNobuko Hijiya, Clinton F Stewart, Yinmei Zhou, et al.
Cancer Research|May 19, 2007
Differential effects of targeted disruption of thiopurine methyltransferase on mercaptopurine and thioguanine pharmacodynamicsChristine Hartford, Erick Vasquez, Matthias Schwab, et al.
Pharmacogenetics and Genomics|April 9, 2014
Host thiopurine methyltransferase status affects mercaptopurine antileukemic effectiveness in a murine modelLaura B Ramsey, Laura J Janke, Mathew J Edick, et al.
Blood|January 26, 2011
Chemotherapeutic agents circumvent emergence of dasatinib-resistant BCR-ABL kinase mutations in a precise mouse model of Philadelphia chromosome-positive acute lymphoblastic leukemiaNidal Boulos, Heather L Mulder, Christopher R Calabrese, et al.
Pediatric Blood & Cancer|December 6, 2021
Dasatinib does not exacerbate dexamethasone-induced osteonecrosis in murine models of acute lymphoblastic leukemia therapyEmily R Finch, Laura J Janke, Lie Li, et al.
Cancer Chemotherapy and Pharmacology|November 20, 2002
A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemiaJohn Carl Panetta, Yuri Yanishevski, Ching-Hon Pui, et al.
Pediatric Blood & Cancer|June 14, 2021
Effects of zoledronic acid on osteonecrosis and acute lymphoblastic leukemia treatment efficacy in preclinical modelsLaura J Janke, Jieun Kim, Monique A Payton, et al.
Blood|December 11, 2008
Acquired variation outweighs inherited variation in whole genome analysis of methotrexate polyglutamate accumulation in leukemiaDeborah French, Wenjian Yang, Cheng Cheng, et al.
Pediatric Blood & Cancer|December 31, 2016
Osteonecrosis is unrelated to hip anatomy in children with acute lymphoblastic leukemiaMary V Portera, Seth E Karol, Colton Smith, et al.
Cancer Chemotherapy and Pharmacology|February 28, 2024
Ommaya reservoir use in pediatric ALL and NHL: a review at St. Jude Children's Research HospitalAlyssa Gaietto, John C Panetta, Jennifer L Pauley, et al.
Pageof 30